The COVID-19 crisis also had a negative impact on gum sales in Singapore as many consumers were not able to commute as freely in order to visit pharmacies and purchase therapeutic chewing gum. Nevertheless, rather than the pandemic, the main factor negatively impacting gum sales in Singapore remains anti-gum legislation, which has been in place since 1992 (Regulation of imports and exports act). With the signing of the Free Trade Agreement between the United States and Singapore in 2004, the reg...
Euromonitor International's Gum in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Bubble Gum, Chewing Gum.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Gum market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Gum in Singapore
Euromonitor International
December 2020
List OF CONTENTS AND TABLES
KEY DATA FINDINGS
2020 IMPACT
Sales continue to be limited by anti-gum legislation and limited availability
Demand for therapeutic gum limited by restricted distribution and controls
Orbit continues to dominate despite declining sales
RECOVERY AND OPPORTUNITIES
Legislation to continue limiting growth
Scope for rising health awareness to boost sales
Growth to be limited by new alternatives and health and environmental concerns
CATEGORY DATA
Table 1 Sales of Gum by Category: Volume 2015-2020
Table 2 Sales of Gum by Category: Value 2015-2020
Table 3 Sales of Gum by Category: % Volume Growth 2015-2020
Table 4 Sales of Gum by Category: % Value Growth 2015-2020
Table 5 Sales of Gum by Flavour: Rankings 2015-2020
Table 6 NBO Company Shares of Gum: % Value 2016-2020
Table 7 LBN Brand Shares of Gum: % Value 2017-2020
Table 8 Distribution of Gum by Format: % Value 2015-2020
Table 9 Forecast Sales of Gum by Category: Volume 2020-2025
Table 10 Forecast Sales of Gum by Category: Value 2020-2025
Table 11 Forecast Sales of Gum by Category: % Volume Growth 2020-2025
Table 12 Forecast Sales of Gum by Category: % Value Growth 2020-2025